Please login to the form below

Not currently logged in
Email:
Password:

Mereo BioPharma

This page shows the latest Mereo BioPharma news and features for those working in and with pharma, biotech and healthcare.

Celgene says no to Mereo’s cancer drug etigilimab

Celgene says no to Mereo’s cancer drug etigilimab

UK biotech will focus on rare disease drugs. Mereo BioPharma has lost Celgene as a partner for anti-TIGIT drug etigilimab, one of two drugs acquired when Mereo merged with OncoMed ... Ahead of the Mereo merger, it decided not to pursue a project focusing

Latest news

  • Mereo’s shareholders back OncoMed takeover

    Deal expected to go through next week. UK company Mereo BioPharma is on the brink of a US listing, via the takeover of troubled US biotech OncoMed, after the deal was ... After the merger goes through, OncoMed will be a wholly-owned subsidiary of Mereo,

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals in July 2015 Pharma deals in July 2015

    Woodford has also been an investor in the deal whereby Novartis spun off three phase II products for an equity stake in a newly formed company, Mereo Biopharma, which raised $119m. ... It is hoped that Immunocore and Mereo are signs that at long last the

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Mereo BioPharma appoints head of patient access and commercial planning Mereo BioPharma appoints head of patient access and commercial planning

    Wills Hughes-Wilson joins the group from Sobi. London, UK-based Mereo BioPharma, has strengthened its team with the addition of Wills Hughes-Wilson, who joins the biopharma as its new ... Dr Denise Scots-Knight, chief executive officer of Mereo BioPharma,

  • Mereo BioPharma appoints CFO Mereo BioPharma appoints CFO

    Richard Jones joins the rare diseases specialist. London, UK-based Mereo BioPharma Group has appointed Richard Jones as chief financial officer and member of the board of directors, effective from early ... Dr Denise Scots-Knight, chief executive of

  • Mereo BioPharma’s Richard Bungay to step down Mereo BioPharma’s Richard Bungay to step down

    Will leave CFO and COO roles in April 2017. Mereo BioPharma's Richard Bungay is set to step down from his roles as chief financial officer and chief operating officer in ... Bungay joined the UK-based clinical stage biopharmaceutical firm in July last

More from appointments
Approximately 3 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics